logo

For the Inventor, By the Inventor

Fuji, Japan

Naokuni Yamawaki

USPTO Granted Patents = 7

Average Co-Inventor Count = 2.8

ph-index = 7

Forward Citations = 99(Granted Patents)


Company Filing History:

goldMedal7 out of 1,297 
 
Asahi Kasei Kogyo Kabushiki Kaisha
 patents

Years Active: 1980-1989

Loading Chart...
7 patents (USPTO):Explore Patents
1. 4839290 - Process for producing cytotoxic T-cells and compositions produced by (1989-06-13),
2. 4627915 - Absorbent of autoantibody and immune complexes, adsorbing device and (1986-12-09),
3. 4576927 - Porous adsorbent for adsorbing low density lipoproteins (1986-03-18),
4. 4430229 - Immune adsorbent and adsorbing device (1984-02-07),
5. 4240376 - Method for keeping aquatic animals alive over long periods of time (1980-12-23),
6. 4202291 - Method for keeping aquatic animals alive over long period of time (1980-05-13),
7. 4182267 - Apparatus for keeping aquatic animals alive over long period of time (1980-01-08),

Title: Naokuni Yamawaki: Innovator in Immunotherapy

Introduction

Naokuni Yamawaki is a prominent inventor based in Fuji, Japan. He has made significant contributions to the field of immunotherapy, holding a total of 7 patents. His work focuses on developing methods and materials that enhance the efficacy and safety of antitumor immunocytes.

Latest Patents

Yamawaki's latest patents include a groundbreaking process for producing cytotoxic T-cells. This method is designed to induce antitumor immunocytes that exhibit excellent cytotoxic activity against tumor cells while ensuring high safety. The process involves contacting leucocytes with an insoluble, antitumor immunocyte-inducing material that links with T cells. The resulting antitumor immunocytes can be easily separated from the inducing material in a ligand-free form, maintaining their effectiveness.

Another notable patent involves an absorbent for autoantibodies and immune complexes. This innovative adsorbent is designed to selectively and efficiently adsorb autoantibodies and immune complexes from body fluids without significantly removing useful substances. It can be integrated into an adsorbing device used in blood purifying apparatuses, enhancing the purification process of blood plasma.

Career Highlights

Yamawaki is currently associated with Asahi Kasei Kogyo Kabushiki Kaisha, a leading company in the field of healthcare and materials. His work at the company has been instrumental in advancing immunotherapy techniques and improving patient outcomes.

Collaborations

Throughout his career, Yamawaki has collaborated with notable colleagues, including Naoya Kominami and Hirokazu Fukumi. These collaborations have fostered innovation and contributed to the development of effective therapeutic solutions.

Conclusion

Naokuni Yamawaki's contributions to immunotherapy through his patents and collaborations highlight his role as a key innovator in the field. His work continues to pave the way for advancements in cancer treatment and patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…